ID   FM37
AC   CVCL_C584
DR   Wikidata; Q54835030
RX   PubMed=7656272;
RX   PubMed=9288767;
RX   PubMed=11225993;
CC   HLA typing: A*02,03; B*07,40; C*03 (PubMed=7656272).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=7656272; DOI=10.1007/BF01527402; PMCID=PMC11037630;
RA   Kirkin, Alexei F.
RA   Petersen, Troels Reichert
RA   Olsen, Anna Catharina
RA   Li, Li
RA   thor Straten, Per
RA   Zeuthen, Jesper
RT   "Generation of human-melanoma-specific T lymphocyte clones defining
RT   novel cytolytic targets with panels of newly established melanoma cell
RT   lines.";
RL   Cancer Immunol. Immunother. 41:71-81(1995).
//
RX   PubMed=9288767;
RA   Guldberg, Per
RA   thor Straten, Per
RA   Birck, Anette
RA   Ahrenkiel, Vibeke
RA   Kirkin, Alexei F.
RA   Zeuthen, Jesper
RT   "Disruption of the MMAC1/PTEN gene by deletion or mutation is a
RT   frequent event in malignant melanoma.";
RL   Cancer Res. 57:3660-3663(1997).
//
RX   PubMed=11225993; DOI=10.1007/s002620000154; PMCID=PMC11036965;
RA   Real, Luis M.
RA   Jimenez, Pilar
RA   Kirkin, Alexei F.
RA   Serrano, Alfonso
RA   Garcia, Aida
RA   Canton, Julia
RA   Zeuthen, Jesper
RA   Garrido, Federico
RA   Ruiz-Cabello Osuna, Francisco
RT   "Multiple mechanisms of immune evasion can coexist in melanoma tumor
RT   cell lines derived from the same patient.";
RL   Cancer Immunol. Immunother. 49:621-628(2001).
//